FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2776802176> ?p ?o ?g. }

• W2776802176 endingPage "433" @default.
• W2776802176 startingPage "427" @default.
• W2776802176 abstract "We have previously reported that PET using 18F-fluoride (NaF PET) for assessment of osseous metastatic disease was associated with substantial changes in intended management in Medicare beneficiaries participating in the National Oncologic PET Registry (NOPR). Here, we use Medicare administrative data to examine the association between NaF PET results and hospice claims within 180 d and 1-y survival. Methods: We classified NOPR NaF PET results linked to Medicare claims by imaging indication (initial staging [IS]; detection of suspected first osseous metastasis [FOM]; suspected progression of osseous metastasis [POM]; or treatment monitoring [TM]) and type of cancer (prostate, lung, breast, or other). Results were classified as definitely positive scan findings versus probably positive scan findings versus negative scan findings for osseous metastasis for IS and FOM; more extensive disease versus no change or less extensive disease for POM; and worse prognosis versus no change or better prognosis for TM, based on the postscan assessment. Our study included 21,167 scans obtained from 2011 to 2014 of consenting NOPR participants aged 65 y or older. Results: The relative risk of hospice claims within 180 d of a NaF PET scan was 2.0-7.5 times higher for patients with evidence of new or progressing osseous metastasis than for those without, depending on indication and cancer type (all P < 0.008). The percentage difference in hospice claims for those with a finding of new or more advanced osseous disease ranged from 3.9% for IS prostate patients to 28% for FOM lung patients. Six-month survival was also associated with evidence of new or increased osseous disease; risk of death was 1.8-5.1 times as likely (all P ≤ 0.0001), with percentage differences of approximately 30% comparing positive and negative scans in patients with lung cancer imaged for IS or FOM. Conclusion: Our analyses demonstrated that NaF PET scan results are highly associated with subsequent hospice claims and, ultimately, with patient survival. NaF PET provides important information on the presence of osseous metastasis and prognosis to assist patients and their physicians when making decisions on whether to select palliative care and transition to hospice or whether to continue treatment." @default.
• W2776802176 created "2018-01-05" @default.
• W2776802176 creator A5044599092 @default.
• W2776802176 creator A5048142039 @default.
• W2776802176 creator A5049988109 @default.
• W2776802176 creator A5067703687 @default.
• W2776802176 creator A5072203753 @default.
• W2776802176 creator A5081792160 @default.
• W2776802176 creator A5090808981 @default.
• W2776802176 creator A5091313701 @default.
• W2776802176 date "2017-12-28" @default.
• W2776802176 modified "2023-10-08" @default.
• W2776802176 title "Hospice Admission and Survival After ¹⁸F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry" @default.
• W2776802176 cites W1995380626 @default.
• W2776802176 cites W2013679695 @default.
• W2776802176 cites W2035824830 @default.
• W2776802176 cites W2044116181 @default.
• W2776802176 cites W2067604161 @default.
• W2776802176 cites W2081235352 @default.
• W2776802176 cites W2081400771 @default.
• W2776802176 cites W2104218059 @default.
• W2776802176 cites W2104565425 @default.
• W2776802176 cites W2110081171 @default.
• W2776802176 cites W2118592725 @default.
• W2776802176 cites W2139524347 @default.
• W2776802176 cites W2139639410 @default.
• W2776802176 cites W2157873228 @default.
• W2776802176 cites W2158110141 @default.
• W2776802176 cites W2264243378 @default.
• W2776802176 cites W2330394332 @default.
• W2776802176 cites W2416549715 @default.
• W2776802176 cites W2588262604 @default.
• W2776802176 cites W2598178324 @default.
• W2776802176 cites W2724500088 @default.
• W2776802176 cites W2733307304 @default.
• W2776802176 cites W2747294052 @default.
• W2776802176 cites W2755559037 @default.
• W2776802176 doi "https://doi.org/10.2967/jnumed.117.205120" @default.
• W2776802176 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6424219" @default.
• W2776802176 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29284672" @default.
• W2776802176 hasPublicationYear "2017" @default.
• W2776802176 type Work @default.
• W2776802176 sameAs 2776802176 @default.
• W2776802176 citedByCount "13" @default.
• W2776802176 countsByYear W27768021762018 @default.
• W2776802176 countsByYear W27768021762019 @default.
• W2776802176 countsByYear W27768021762022 @default.
• W2776802176 countsByYear W27768021762023 @default.
• W2776802176 crossrefType "journal-article" @default.
• W2776802176 hasAuthorship W2776802176A5044599092 @default.
• W2776802176 hasAuthorship W2776802176A5048142039 @default.
• W2776802176 hasAuthorship W2776802176A5049988109 @default.
• W2776802176 hasAuthorship W2776802176A5067703687 @default.
• W2776802176 hasAuthorship W2776802176A5072203753 @default.
• W2776802176 hasAuthorship W2776802176A5081792160 @default.
• W2776802176 hasAuthorship W2776802176A5090808981 @default.
• W2776802176 hasAuthorship W2776802176A5091313701 @default.
• W2776802176 hasBestOaLocation W27768021761 @default.
• W2776802176 hasConcept C121608353 @default.
• W2776802176 hasConcept C126322002 @default.
• W2776802176 hasConcept C126838900 @default.
• W2776802176 hasConcept C143998085 @default.
• W2776802176 hasConcept C2775930923 @default.
• W2776802176 hasConcept C2779013556 @default.
• W2776802176 hasConcept C2779134260 @default.
• W2776802176 hasConcept C2780192828 @default.
• W2776802176 hasConcept C2989005 @default.
• W2776802176 hasConcept C3019894029 @default.
• W2776802176 hasConcept C530470458 @default.
• W2776802176 hasConcept C71924100 @default.
• W2776802176 hasConceptScore W2776802176C121608353 @default.
• W2776802176 hasConceptScore W2776802176C126322002 @default.
• W2776802176 hasConceptScore W2776802176C126838900 @default.
• W2776802176 hasConceptScore W2776802176C143998085 @default.
• W2776802176 hasConceptScore W2776802176C2775930923 @default.
• W2776802176 hasConceptScore W2776802176C2779013556 @default.
• W2776802176 hasConceptScore W2776802176C2779134260 @default.
• W2776802176 hasConceptScore W2776802176C2780192828 @default.
• W2776802176 hasConceptScore W2776802176C2989005 @default.
• W2776802176 hasConceptScore W2776802176C3019894029 @default.
• W2776802176 hasConceptScore W2776802176C530470458 @default.
• W2776802176 hasConceptScore W2776802176C71924100 @default.
• W2776802176 hasIssue "3" @default.
• W2776802176 hasLocation W27768021761 @default.
• W2776802176 hasLocation W27768021762 @default.
• W2776802176 hasLocation W27768021763 @default.
• W2776802176 hasLocation W27768021764 @default.
• W2776802176 hasOpenAccess W2776802176 @default.
• W2776802176 hasPrimaryLocation W27768021761 @default.
• W2776802176 hasRelatedWork W144521535 @default.
• W2776802176 hasRelatedWork W1899936169 @default.
• W2776802176 hasRelatedWork W2023654245 @default.
• W2776802176 hasRelatedWork W2212921542 @default.
• W2776802176 hasRelatedWork W2411890706 @default.
• W2776802176 hasRelatedWork W3033874287 @default.
• W2776802176 hasRelatedWork W3088410393 @default.
• W2776802176 hasRelatedWork W3181412252 @default.
• W2776802176 hasRelatedWork W377899687 @default.

• next